BMC Complementary and Alternative Medicine · 2016 · 288 citations · 29 references
Life SciencesBiochemistryNutritional SciencesEnzymologyFruit SciencePlant BiochemistryDiabetes ManagementDiabetes MellitusDiabetes Mellitus BiochemistryFruit BiochemistryFruit PhysiologyAntidiabetic ActivityBlood Glucose RegulationCompetitive InhibitionFruit Enzyme ActivityFruit PhytochemicalsGlucose-lowering TherapyMedicinal Food PlantsPostprandial Glucose Regulation
BACKGROUND: α-amylase and α-glucosidase digest the carbohydrates and increase the postprandial glucose level in diabetic patients. Inhibiting the activity of these two enzymes can control postprandial hyperglycemia, and reduce the risk of developing diabetes. Bitter gourd or balsam pear is one of the important medicinal plants used for controlling postprandial hyperglycemia in diabetes patients. However, there is limited information available on the presence of α-amylase and α-glucosidase inhibiting compounds. In the current study, the protein extracts from the fruits of M. charantia var. charantia (MCC) and M. charantia var. muricata (MCM) were tested for α-amylase and α-glucosidase inhibiting activities in vitro, and glucose lowering activity after oral administration in vivo. RESULTS: The protein extract from both MCC and MCM inhibited the activity of α-amylase and α-glucosidase through competitive inhibition, which was on par with Acarbose as indicated by in vitro percentage of inhibition (66 to 69 %) and IC50 (0.26 to 0.29 mg/ml). Both the protein extracts significantly reduced peak blood glucose and area under the curve in Streptozotocin-induced diabetic rats, which were orally challenged with starch and sucrose. CONCLUSIONS: Protein extracts from the fruits of the two varieties of bitter gourd inhibited α-amylase and α-glucosidase in vitro and lowered the blood glucose level in vivo on par with Acarbose when orally administrated to Streptozotocin-induced diabetic rats. Further studies on mechanism of action and methods of safe and biologically active delivery will help to develop an anti-diabetic oral protein drug from these plants.
29
Delf Schmidt, Wolf B. Frommer, Bodo Junge et al. · Die Naturwissenschaften · 1977 · 468 citations
The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts
Sinéad Lordan, Thomas J. Smyth, Anna Soler‐Vila et al. · Food Chemistry · 2013 · 434 citations